MUSOLINO, Caterina
 Distribuzione geografica
Continente #
EU - Europa 12.356
NA - Nord America 10.484
AS - Asia 6.206
SA - Sud America 2.387
AF - Africa 212
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 7
Totale 31.667
Nazione #
US - Stati Uniti d'America 10.250
RU - Federazione Russa 6.250
SG - Singapore 2.772
BR - Brasile 2.074
CN - Cina 1.632
IE - Irlanda 1.519
SE - Svezia 1.273
IT - Italia 803
HK - Hong Kong 704
DE - Germania 531
FR - Francia 415
UA - Ucraina 385
VN - Vietnam 361
FI - Finlandia 279
GB - Regno Unito 278
PL - Polonia 241
IN - India 156
AR - Argentina 114
CA - Canada 98
MX - Messico 83
BD - Bangladesh 78
TR - Turchia 72
ZA - Sudafrica 66
AT - Austria 60
HU - Ungheria 60
BE - Belgio 58
EC - Ecuador 58
ID - Indonesia 54
IQ - Iraq 52
NL - Olanda 50
ES - Italia 45
JP - Giappone 42
CO - Colombia 39
MA - Marocco 37
PK - Pakistan 36
UZ - Uzbekistan 34
KE - Kenya 30
VE - Venezuela 26
EG - Egitto 22
PY - Paraguay 21
IR - Iran 19
TN - Tunisia 18
CL - Cile 17
CZ - Repubblica Ceca 17
PH - Filippine 17
AE - Emirati Arabi Uniti 16
BO - Bolivia 14
HN - Honduras 14
LT - Lituania 14
SA - Arabia Saudita 14
DO - Repubblica Dominicana 13
JO - Giordania 13
AZ - Azerbaigian 12
IL - Israele 12
UY - Uruguay 11
GR - Grecia 10
KR - Corea 10
NP - Nepal 10
PE - Perù 10
KG - Kirghizistan 9
OM - Oman 9
PS - Palestinian Territory 9
RO - Romania 9
AU - Australia 8
NO - Norvegia 8
BG - Bulgaria 7
LB - Libano 7
MY - Malesia 7
SN - Senegal 7
AL - Albania 6
AO - Angola 6
CH - Svizzera 6
CR - Costa Rica 6
DK - Danimarca 6
JM - Giamaica 6
KZ - Kazakistan 6
LV - Lettonia 6
NZ - Nuova Zelanda 6
SY - Repubblica araba siriana 6
TW - Taiwan 6
CI - Costa d'Avorio 5
GE - Georgia 5
SK - Slovacchia (Repubblica Slovacca) 5
TH - Thailandia 5
DZ - Algeria 4
ET - Etiopia 4
EU - Europa 4
NI - Nicaragua 4
PA - Panama 4
RS - Serbia 4
AM - Armenia 3
BH - Bahrain 3
KW - Kuwait 3
LY - Libia 3
XK - ???statistics.table.value.countryCode.XK??? 3
BY - Bielorussia 2
CY - Cipro 2
EE - Estonia 2
GH - Ghana 2
GY - Guiana 2
Totale 31.634
Città #
Moscow 1.902
Ashburn 1.644
Dublin 1.518
Singapore 1.494
Chandler 1.272
Dallas 1.030
Jacksonville 801
Nyköping 727
Hong Kong 704
Beijing 581
San Jose 365
Messina 352
The Dalles 343
Princeton 279
Dearborn 268
Medford 258
Lauterbourg 249
Los Angeles 237
Warsaw 219
Des Moines 214
Cambridge 209
Ann Arbor 185
São Paulo 181
New York 165
Boardman 139
Munich 126
Buffalo 112
Ho Chi Minh City 104
Tianjin 88
Hanoi 82
Woodbridge 77
Redondo Beach 74
Frankfurt am Main 71
Rio de Janeiro 64
Wilmington 64
Belo Horizonte 63
Budapest 59
Brussels 57
Guangzhou 57
San Mateo 56
Council Bluffs 54
Jinan 51
Vienna 50
Johannesburg 43
Brasília 42
Santa Clara 42
Turku 42
Nanjing 41
Orem 41
Shenyang 41
Tokyo 41
Chennai 39
Montreal 38
Houston 37
Hebei 36
Lancaster 36
Seattle 36
Porto Alegre 34
Brooklyn 33
Helsinki 33
Pune 33
Shanghai 33
Bremen 32
Nuremberg 31
London 30
Milan 28
Tashkent 28
Curitiba 27
Dong Ket 27
Hangzhou 27
Jakarta 27
Quito 27
Stockholm 27
Zhengzhou 27
Amsterdam 26
Nairobi 26
Atlanta 25
Denver 23
Poplar 23
Rome 23
Strasbourg 23
San Francisco 22
Boston 21
Guarulhos 21
Ningbo 20
Ribeirão Preto 20
Chicago 19
Campinas 18
Düsseldorf 18
Haikou 18
Manchester 18
Palermo 18
Recife 18
Salvador 18
Shenzhen 17
Istanbul 16
Lahore 16
Mexico City 16
Baghdad 15
Haiphong 15
Totale 18.217
Nome #
Altered Microrna Expression Profile in the peripheral Lymphomonocytes of Multiple Myeloma Patients with Bisphosphonate-Induced Osteonecrosis of the Jaw 298
Diagnostic utility of Sudoscan for detecting Bortezomib-induced painful neuropathy 251
A multivariate analysis of Multiple Myeloma subtype plasma cells 246
A micro-Raman spectroscopic investigation of leukemic U-937 cells in aged cultures 240
SIRT1 and SIRT2 Expression correlates with advanced disease and bone lesions in Multiple Myeloma 240
Altered microRNA expression profile in the peripheral lymphoid compartment of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw 234
Bisphosphonates induce apoptosis of circulating endothelial cells in multiple myeloma patients and in subjects with bisphosphonate-induced osteonecrosis of the jaws 210
Effect of therapeutic plasma exchange on plasma levels of oxidative biomarkers in a patient with thrombotic thrombocytopenic purpura 207
E rosette formation in B cell chronic lymphocytic leukemia. 201
Corneal Structural Changes in Nonneoplastic and Neoplastic Monoclonal Gammopathies 198
MDR-1 gene polymorphisms G2677T and C3435T in a case of Hodgkin's variant of Richter's syndrome 198
Absence of the V617F JAK2 Mutation in the Lymphoid Compartment in a Patient with Essential Thrombocythemia and B-Chronic Lymphocytic Leukemia and in Two Relatives with Lymphoproliferative Disorders 196
Disappearance of Acquired Hemophilia A after Complete Remission in a Multiple Myeloma Patient. 193
Comportamento di alcuni indici della fibrinolisi in dislipidemici in corso di trattamento con sinfibrato" 192
Adoptive immunotherapy for hematological malignancies: Current status and new insights in chimeric antigen receptor T cells 192
Aggregazione piastrinica in dislipidemici in corso di trattamento con simfibrato 191
Curcumin ameliorates the in vitro efficacy of carfilzomib in human multiple myeloma U266 cells targeting p53 and NF-kB pathways 188
Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies 187
Evaluation of the AGE/sRAGE Axis in Patients with Multiple Myeloma 186
ASSETTO EMATOLOGICO DI UN GRUPPO DI SOGGETTIAFFETTI DA MORBO DI COOLEY:STUDIO DEL COMPORTAMENTO DELL'ERITROPOIETINA PLASMATICA 185
A rare spinal localization of gray zone lymphoma without mediastinal involvement: A case report and review of literature 185
Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (Review). 183
Absence of the V617F JAK2 mutation in the lymphoid compartment in a patient with essential thrombocythemia and B-chronic lymphocytic leukemia and n two relatives with lymphoproliferative disorders 182
Novel therapeutic strategies in multiple myeloma: role of the heat shock protein inhibitors 181
Efficacia della chemioterapia convenzionale ad alte dosi in un caso di mieloma multiplo IgM primitivamente doppio-refrattario ai nuovi farmaci 180
Bisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma and breast cancer. 179
Raman spectroscopy differentiates between sensitive and resistant multiple myeloma cell lines 175
Risk stratification and early cardiotoxicity identification: organizational advantages and clinical impact of intrahospital cardiotoxicity network 175
Cerebral venous sinus thrombosis (CVST) associated with SARS-CoV-2 vaccines: clues for an immunopathogenesis common to CVST observed in COVID-19 175
Circulating levels of intercellular adhesion molecule-1 (ICAM-1) and soluble interleukin 2 receptors (IL-2R) in patients with B cell chronic lymphocytic leukaemia. 173
Cutaneous adverse reactions to lenalidomide. 172
ABERRANT EXPRESSION OF CANCER TESTIS ANTIGENS IN HEMATOLOGIC MALIGNANCIES 172
Concentration of circulating endothelial progenitor cells (EPC) in normal pregnancy and in pregnant women with diabetes and hypertension 172
Avascular Necrosis of Bone in Leukemia and Osteonecrosis of Jaw by Bisphosphonates 172
Anxiety, Depression, Distress, and Resilience in Patients with Haematological Malignancies. The Effect of Nine Weeks of Psychological Support on Psychological Status and Stress Biological Markers 172
Challenge test to bisphosphonates in patients with hypersensitivity reactions to drugs. 171
L'ipersplenismo: attualità e prospettive future 171
Changes in serum interleukin-8 and sRAGE levels in multiple myeloma patients 169
Vaccination of multiple myeloma: Current strategies and future prospects 169
Angiogenesis in patients with biphosphonate-associated osteonecrosis of the jaw 167
Beta 2 microglobulina ed emopatie maligne 167
Antiresorptive Agents and Anti-Angiogenesis Drugs in the Development of Osteonecrosis of the Jaw. 166
Increased levels of the soluble adhesion molecule E-selectin in patients with chronic myeloproliferative disorders and thromboembolic complications 165
Telomerase and telomere biology in hematological diseases: A new therapeutic target 162
Assenza della mutazione JAK2 V617F nel compartimento linfoide di un paziente affetto da trombocitemia essenziale e leucemia linfatica cronica a cellule B ed in due parenti affetti da disordini linfoproliferativi 161
A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma 161
Circulating endothelial progenitor cells and angiogenic serum factors in patients with chronic myeloproliferative diseases 157
Amyloid myopathy presenting with rhabdomyolysis: Evidence of complement activation 157
Myeloma cells induce the accumulation of activated CD94low NK cells by cell-to-cell contacts involving CD56 molecules 157
Low-energy laser irradiation promotes cellular damage in glucocorticoid-resistant multiple myeloma cells. 155
Serum levels of interleukin-16 in lymphoid malignancies. 155
ARA-C a basse dosi nelle sindrome mielodisplastiche in differenti stati evolutivi 155
[Calcium and endocrine pancreas secretion. II. Effects of an infusion of calcium on insulin and glucagon secretion induced by intravenous administration of glucose]. 155
A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients 155
Global cardiovascular assessment in patients with PH+ chronic myeloid leukaemia treated with TKI: long-term follow-up 155
Phage-AgNPs complex as SERS probe for U937 cell identification 154
Circulating levels of intercellular adhesion Molecule-1 (ICAM-1) and soluble Interleukin 2 receptors(IL-2R) in patients with B cell Chronic Lynphocityc Leukemia 153
Vaccination strategies in lymphoproliferative disorders: Failures and successes 153
Successful management of a pregnant patient with chronic myeloid leukemia receiving standard dose imatinib 152
Cancer and sars-cov-2 infection: Diagnostic and therapeutic challenges 152
Carbonyl groups serum levels are associated with CD38 expression in patients with B chronic lymphocytic leucemia. 151
Risk of occult hepatitis B virus infection reactivation in patients with solid tumours undergoing chemotherapy 150
Curcumin Ameliorates the In Vitro Efficacy of Carfilzomib in Human Multiple Myeloma U266 Cells Targeting p53 and NF-κB Pathways. 150
Hepatitis B Virus Causes Epigenetic Induction of Interleukin-8Production which in Turn Inhibits Interferon-alfa Antiviral Activity 149
MiRNome expression is deregulated in the peripheral lymphoid compartment of multiple myeloma 149
Association of osteonecrosis of the jaws and POEMS syndrome in a patient assuming rituximab. 149
Allergy and risk of hematologic malignancies: Associations and mechanisms. 148
A population-based study of chronic myeloid leukemia patients treated with imatinib in first line 148
Anticancer activity of rosmarinus officinalis L.: Mechanisms of action and therapeutic potentials 148
Increase in serum protein carbonyl groups is associated with more advanced stage of disease in multiple myeloma patients. 147
The cancer stem cell hypothesis: a guide to potential molecular targets. 146
Standardisation of minimal residual disease in multiple myeloma 146
Immunohistochemical evaluation of sarcoglycans and integrins in gingival epithelium of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw. 145
MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an impact on susceptibility and prognosis. 145
Antiproliferative effects of st. John’s wort, its derivatives, and other hypericum species in hematologic malignancies 142
Patients with bisphosphonate-associated osteonecrosis of the jaw have unmodified levels of soluble vascular endothelial growth factor receptor 1. 141
Changes in advanced oxidation protein products, advanced glycation end products, and s-nitrosylated proteins, in patients affected by polycythemia vera and essential thrombocythemia 141
Possible role of Interleuki-31/33 Axis in Imatinib Mesylate-Associated Skin Toxicity 141
FITC-labelled clone from phage display for direct detection of leukemia cells in blood 141
Decreased plasma levels of IL-33 could contribute to the altered function of Th2 Iymphocytes in patients with poIycythemia vera and essential thrombocythemia. 140
How gene polymorphisms can influence clinical response and toxicity following R-CHOP therapy in patients with diffuse large B cell lymphoma 140
Role of the microbiota in hematologic malignancies. 138
Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma. 137
Cardiac involvement in patients with hematologic malignancies. 135
The metabolomic signature of hematologic malignancies 135
Antitumorigenic action of nelfinavir: Effects on multiple myeloma and hematologic malignancies (Review) 135
DIFFERENT DAILY BLOOD GLUCOSE CONTROL AND FREE INSULIN LEVELS DURING TREATMENT WITH MIXTURES OF SOLUBLE AND LENTE OR SOLUBLE AND NPH SEMISYNTHETIC HUMAN INSULINS. 134
Effetti di uno stress fisico sulla funzione pistrinica e su alcuni parametri emocoagulativi e della fibrinolisi 134
Efficacy of biosimilar granulocyte colony-stimulating factor versus originator granulocyte colony-stimulating factor in peripheral blood stem cell mobilization in de novo multiple myeloma patients 133
Patients with bisphosphonates-associated osteonecrosis of the jaw have reduced circulating endothelial cells 133
Monocytes and lymphocytes as active participants in the pathogenesis of experimental shock 132
A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy. 131
Castleman–Kojima disease (TAFRO syndrome) in a Caucasian patient: A rare case report and review of the literature 131
Oxidative stress in oncohematologic diseases: an update. 130
Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapies. 128
Immunohistochemical evaluation of sarcoglycans and integrin in gingival epithelium of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw 128
Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies 128
SERUM LEVELS OF 2', 5 OLIGOADENYLATE SYNTHETASE DURING INTERFERON THERAPY IN PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC- LEUKEMIA 126
Interleukin 22 is increased and correlated with CD38 expression in patients with B-chronic lymphocytic leukemia 125
Raman spectroscopy is able to discriminate between CD138-/CD138+ plasmacells of multiple myeloma patients. 125
Totale 16.430
Categoria #
all - tutte 106.917
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.917


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021463 0 0 0 0 0 0 0 0 0 243 120 100
2021/20221.637 16 118 24 73 54 23 101 65 54 225 222 662
2022/20234.587 409 392 215 409 312 466 53 231 1.862 27 146 65
2023/20241.087 100 197 70 85 98 247 26 71 11 27 16 139
2024/20255.537 136 85 99 337 304 143 91 1.253 1.479 316 463 831
2025/202614.737 702 1.031 1.190 1.087 1.338 3.266 1.892 1.842 1.867 522 0 0
Totale 32.098